Skip to content

Glycaemic Index and satiety of Beta-Glucan Barley

Glycaemic Index and satiety of Beta-Glucan Barley - GIGS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010803
Enrollment
20
Registered
2016-07-25
Start date
2016-05-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin- and glucose metabolism

Interventions

Group 1: Within a four week, monocentric cross-over study, study participants receive at intervals of 7 days one of the four study products (each cooked) in random order: parboiled rice Amount of st

Sponsors

Institut für Lebensmittelwissenschaft und Humanernährung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy study participants; BMI 18,0-28,0 kg/m²; written consent after information about study contents and study procedure; ability and willingness of study participants to follow study leaders instructions

Exclusion criteria

Exclusion criteria: Smokers; high performance athlete; hormonal illnesses (hyperthyroidism e.g.); acute potassium and magnesium deficiencies; severe chronic illness (Cancer, diabetes mellitus Typ I e.g.) manifest coronary heart disease(angina pectoris, heart failure e.g.), kidney insufficiency or liver diseases; chronic gastroinestinal diseases (colitis ulcerosa, morbus crohn, pancreas insuffiency); known endocrine and immunological diseases; familial diabetes mellitus; treatment with not-insulinreleasing antidiabetics (guar, ascarbose e.g.); chronic intake of corticosteroids (except inhalativ) and psychotropic drugs, intolerances or allergies regarding study product ingredientes; regular intake of laxatives; pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Glycemic Index (Parameter: Glucose and Insulin in Blood); Subjective Satiety (Questionnaire) Blood draw and determination of satiety at time point 0 (Start), 15 min (after start), 30 min (after start), 45 min (after start), 60 min (after start), 90 min (after start) and 120 min (after start)

Secondary

MeasureTime frame
Changes of fasting glucose and insulin; general information about health status; drug intake; anthropometric data: height, weight; security parameter (creatinin, uric acid, liver parameter)

Countries

Germany

Contacts

Public ContactIsabel Behrendt

Institut für Lebensmittelwissenschaft und Humanernährung

behrendt@nutrition.uni-hannover.de0511 762 3317

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026